State Of Wisconsin Investment Board Ocugen, Inc. Transaction History

State Of Wisconsin Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.87 $14,623 - $24,635	-13,174 Reduced 5.98%	207,128 $269,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $5,647 - $10,003	3,227 Added 1.49%	220,302 $392,000
Q2 2022 Aug 15, 2022	SELL	$1.83 - $3.45 $39,756 - $74,951	-21,725 Reduced 9.1%	217,075 $493,000
Q2 2021 Aug 12, 2021	BUY	$5.52 - $15.68 $1.32 Million - $3.74 Million	238,800 New	238,800 $1.92 Million

123

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.